Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP646734.RAaB-FAMP2AblEyelZo8CRsFLqBnd4pEI5i3EwfQlvNZU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP646734.RAaB-FAMP2AblEyelZo8CRsFLqBnd4pEI5i3EwfQlvNZU130_assertion type Assertion NP646734.RAaB-FAMP2AblEyelZo8CRsFLqBnd4pEI5i3EwfQlvNZU130_head.
- NP646734.RAaB-FAMP2AblEyelZo8CRsFLqBnd4pEI5i3EwfQlvNZU130_assertion description "[Monoclonal antibodies directed against the EGF-receptor (EGFR) have recently been approved for the treatment of metastatic colorectal cancer (CRC) patients with EGFR-positive tumors at immunohistochemistry (IHC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646734.RAaB-FAMP2AblEyelZo8CRsFLqBnd4pEI5i3EwfQlvNZU130_provenance.
- NP646734.RAaB-FAMP2AblEyelZo8CRsFLqBnd4pEI5i3EwfQlvNZU130_assertion evidence source_evidence_literature NP646734.RAaB-FAMP2AblEyelZo8CRsFLqBnd4pEI5i3EwfQlvNZU130_provenance.
- NP646734.RAaB-FAMP2AblEyelZo8CRsFLqBnd4pEI5i3EwfQlvNZU130_assertion SIO_000772 18154448 NP646734.RAaB-FAMP2AblEyelZo8CRsFLqBnd4pEI5i3EwfQlvNZU130_provenance.
- NP646734.RAaB-FAMP2AblEyelZo8CRsFLqBnd4pEI5i3EwfQlvNZU130_assertion wasDerivedFrom befree-2016 NP646734.RAaB-FAMP2AblEyelZo8CRsFLqBnd4pEI5i3EwfQlvNZU130_provenance.
- NP646734.RAaB-FAMP2AblEyelZo8CRsFLqBnd4pEI5i3EwfQlvNZU130_assertion wasGeneratedBy ECO_0000203 NP646734.RAaB-FAMP2AblEyelZo8CRsFLqBnd4pEI5i3EwfQlvNZU130_provenance.